Medicare Enrolled
Dr. Manjesh Lingamurthy, M.D.
Hematology & Oncology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lingamurthy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lingamurthy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lingamurthy
Dr. Manjesh Lingamurthy is a hematology & oncology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lingamurthy performed 70,526 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lingamurthy received a total of $21,819 from 110 pharmaceutical and/or device companies across 1241 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lingamurthy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 12% volume in FL
$21,819 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗70,526
Medicare services
Top 12% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
23,100 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,750 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 12,180 | $18 | $47 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
5,370 | $5 | $12 |
| Iron infusion (Monoferric) | 4,700 | $17 | $43 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,886 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,632 | $8 | $16 |
| Cetirizine hydrochloride injection, 0.5 mg An injection containing 0.5 mg of cetirizine hydrochloride, an antihistamine medication. |
920 | $12 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 860 | $1 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $64 | $182 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
540 | $12 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $91 | $256 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
504 | $11 | $28 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
338 | $131 | $363 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
263 | $98 | $267 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
183 | $54 | $149 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
183 | $6 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
176 | $48 | $132 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
169 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
127 | $22 | $57 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
116 | $1 | $4 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
76 | $49 | $130 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
51 | $17 | $52 |
| New patient office visit, complex (60-74 min) | 45 | $169 | $447 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
43 | $10 | $25 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
42 | $2 | $5 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
38 | $25 | $67 |
| Same-day hospital admission and discharge, moderate complexity This code covers initial hospital care for a patient admitted and discharged on the same day. It applies when the visit involves moderate medical decision making and lasts at least 70 minutes. |
34 | $125 | $333 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
28 | $67 | $198 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $94 | $240 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $121 | $338 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
29.8% high complexity
65.4% medium
4.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,819
Total received (2018-2024)
Avg $3,117/year across 7 years
Top 24% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
110
Companies
1,241
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,881
2023
$3,432
2022
$3,740
2021
$2,691
2020
$3,085
2019
$2,905
2018
$2,084
Payments by company (2024)
PFIZER INC.
$309
Novartis Pharmaceuticals Corporation
$269
Daiichi Sankyo Inc.
$264
Takeda Pharmaceuticals U.S.A., Inc.
$241
Merck Sharp & Dohme LLC
$202
GlaxoSmithKline, LLC.
$190
Lilly USA, LLC
$178
Janssen Biotech, Inc.
$155
BeiGene USA, Inc.
$130
Celgene Corporation
$123
Incyte Corporation
$113
JAZZ PHARMACEUTICALS INC.
$111
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
PharmaEssentia USA Corporation
$105
SOBI, INC
$101
Regeneron Healthcare Solutions, Inc.
$100
ARRAY BIOPHARMA INC
$95
Genentech USA, Inc.
$91
Eisai Inc.
$88
ABBVIE INC.
$86
E.R. Squibb & Sons, L.L.C.
$84
Fennec Pharmaceuticals, Inc.
$77
Aveo Pharmaceuticals, Inc.
$62
Gilead Sciences, Inc.
$61
AstraZeneca Pharmaceuticals LP
$58
TAIHO ONCOLOGY, INC.
$55
SERVIER PHARMACEUTICALS LLC
$49
EMD Serono, Inc.
$41
Kyowa Kirin, Inc.
$38
Genmab U.S., Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Azurity Pharmaceuticals, Inc.
$23
Karyopharm Therapeutics Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Mirati Therapeutics, Inc.
$22
GENZYME CORPORATION
$19
Astellas Pharma US Inc
$18
Blueprint Medicines Corporation
$18
Agios Pharmaceuticals, Inc.
$18
Tempus AI, Inc
$17
Kite Pharma, Inc.
$17
Amneal Pharmaceuticals LLC
$17
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 21.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,300
PFIZER INC.
$1,321
Merck Sharp & Dohme Corporation
$1,136
Janssen Biotech, Inc.
$906
Daiichi Sankyo Inc.
$902
Genentech USA, Inc.
$888
Lilly USA, LLC
$827
E.R. Squibb & Sons, L.L.C.
$750
Celgene Corporation
$611
Incyte Corporation
$598
Merck Sharp & Dohme LLC
$555
GlaxoSmithKline, LLC.
$545
Seagen Inc.
$507
GENZYME CORPORATION
$484
AstraZeneca Pharmaceuticals LP
$434
Takeda Pharmaceuticals U.S.A., Inc.
$417
BeiGene USA, Inc.
$395
Regeneron Healthcare Solutions, Inc.
$394
Gilead Sciences, Inc.
$365
Bayer HealthCare Pharmaceuticals Inc.
$356
Astellas Pharma US Inc
$331
ARRAY BIOPHARMA INC
$255
Eisai Inc.
$255
EMD Serono, Inc.
$253
Boehringer Ingelheim Pharmaceuticals, Inc.
$249
Foundation Medicine, Inc.
$235
Kite Pharma, Inc.
$214
JAZZ PHARMACEUTICALS INC.
$201
SOBI, INC
$175
Rigel Pharmaceuticals, Inc.
$172
ABBVIE INC.
$170
Clovis Oncology, Inc.
$168
PUMA BIOTECHNOLOGY, INC.
$163
EISAI INC.
$158
Exelixis Inc.
$156
Pharmacyclics LLC, An AbbVie Company
$156
PharmaEssentia USA Corporation
$149
Karyopharm Therapeutics Inc.
$148
Dova Pharmaceuticals
$145
TerSera Therapeutics LLC
$144
Amgen Inc.
$132
AbbVie Inc.
$128
Seattle Genetics, Inc.
$114
Myovant Sciences Inc.
$102
Myriad Genetic Laboratories, Inc.
$96
AVEO Pharmaceuticals, Inc.
$95
SERVIER PHARMACEUTICALS LLC
$90
Mirati Therapeutics, Inc.
$83
Sobi, Inc
$83
Global Blood Therapeutics, Inc.
$82
Aveo Pharmaceuticals, Inc.
$79
Fennec Pharmaceuticals, Inc.
$77
Immunomedics, Inc.
$77
AbbVie, Inc.
$75
Puma Biotechnology, Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$74
Sun Pharmaceutical Industries Inc.
$73
Agios Pharmaceuticals, Inc.
$68
Helsinn Therapeutics (U.S.), Inc.
$66
Sysmex Inostics Inc
$63
Jazz Pharmaceuticals Inc.
$60
Amneal Pharmaceuticals LLC
$60
CTI BioPharma Corp.
$59
TAIHO ONCOLOGY, INC.
$55
ADC Therapeutics America, Inc.
$53
Kyowa Kirin, Inc.
$52
Array BioPharma Inc.
$50
G1 Therapeutics, Inc.
$48
Celltrion USA Inc.
$47
GE HealthCare
$46
Sumitomo Pharma America, Inc.
$46
Stemline Therapeutics Inc.
$46
Genmab U.S., Inc.
$46
TOLMAR Pharmaceuticals, Inc.
$41
Acrotech Biopharma LLC
$41
Pharmacyclics LLC, an AbbVie Company
$40
EUSA Pharma (US) LLC
$40
Fortovia Therapeutics, Inc.
$39
Apellis Pharmaceuticals, Inc.
$39
AMAG Pharmaceuticals, Inc.
$37
Coherus Biosciences Inc.
$30
INSYS Therapeutics Inc
$30
MEDIVATION FIELD SOLUTIONS LLC
$27
Sirtex Medical Inc
$27
Alexion Pharmaceuticals, Inc.
$25
Azurity Pharmaceuticals, Inc.
$23
Secura Bio, Inc.
$23
Heron Therapeutics, Inc.
$22
Epizyme, Inc.
$21
Acrotech Biopharma Inc.
$21
Telix Pharmaceuticals
$20
Midatech Pharma US Inc
$19
Pharmacosmos Therapeutics Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
ORGANOGENESIS INC.
$18
Blueprint Medicines Corporation
$18
Tempus AI, Inc
$17
Epizyme, Inc.,
$16
Servier Pharmaceuticals LLC
$15
Advanced Accelerator Applications
$15
Taiho Oncology, Inc.
$14
SANOFI-AVENTIS U.S. LLC
$14
Boston Scientific Corporation
$14
Acceleron Pharma, Inc.
$14
Medtronic USA, Inc.
$13
MAYNE PHARMA INC.
$13
MorphoSys, US Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$12
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Spectrum Pharmaceuticals Inc.
$12
Top 3 companies account for 21.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gelclair · HEMADY · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OJJAARA · ONCASPAR · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · Puraply · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYNCHROMED · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · WATCHMAN · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · Zuplenz · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
17
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lingamurthy is a mixed practice specialist, with above-average Medicare volume (top 12% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lingamurthy experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Lingamurthy performed 23,100 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lingamurthy receive payments from pharmaceutical companies?
Yes. Dr. Lingamurthy received a total of $21,819 from 110 companies across 1,241 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lingamurthy's costs compare to other hematology & oncology specialists in Sarasota?
Dr. Lingamurthy's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lingamurthy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sarasota
Browse hematology & oncology specialists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology